: Schematic representation of the assembly of Gαβγ subunits on a baculovirus. (A) (1) First one of the two α-subunits with an internal hexahistidine-tag are cloned into the donor vector "pIDC LIC" with the help of ligation independent cloning (LIC). (2) A new expression cassette is inserted with the help of the multiplication module (see panel (B) for details). (3) One of the five β-subunits is cloned into the α i1 -or α sL -containing "pIDC α LIC" derivative again via LIC, resulting in 10 different Gαβ combinations. (4) Each one of twelve N-terminally HA-tagged γ-subunits is cloned into the acceptor vector "pFL LIC" by LIC. (5) With the help of loxP sites (violet circles) an in vitro Cre recombination is performed. This results in 120 different Gαβγ combinations with a subunit gene stoichiometry of 1:1:1 on one transfer vector, where each of the subunit genes is under the control of a polyhedrin promoter (light brown triangle). (6) Transfer vectors are separately transformed into E. coli DH10 EMBacY cells. There, a transposition with Tn7, expressed in these cells, of the expression cassettes into the baculovirus genome takes place (sequences between the two recognition sites (black squares); part indicated by red dotted line). (7) The virus genomes are isolated and then transfected into Sf9 cells, leading to production of the first virus generation. The vector pIDC contains a chloramphenicol resistance gene (Cm R ), pFL an ampicillin resistance gene (Amp R ). (B) Use of the multiplication module to place two (or more) genes on one pIDC vector. In the cloning strategy presented here the pIDC vector containing the α-subunit ("pIDC α") is linearized by the action of the homing endonuclease PI-SceI. Of the second vector ("pIDC LIC") the "empty" expression module (promoter, LIC site and polyadenylation site (not shown for clarity)) is excised by PI-SceI and BstXI (recognition sequences shown at the bottom of the panel). As BstXI-generated overhangs have been designed (general recognition sequence: 5'-CCANNNNNNTGG-3') to be compatible to PI-SceI overhangs, the expression cassette can be inserted into linearized "pIDC α" yielding "pIDC α LIC". As a result of the cloning the original PI-SceI site of the recipient vector is destroyed, while a new PI-SceI site is generated downstream of the newly inserted expression module, which can again be utilized to integrate another module. (C) DNA sequences describing promoter region, cloning site/gene and polyadenylation site of the used constructs. 1) Sequence of vector pIDC or pFL after inserting oligonucleotides between BamHI and PstI containing a designed LIC cassette (blue) without any insert. The full sequence of the polyhedrin promoter (light brown) and part of the SV40 polyadenylation site (SV40 pA; pink) are shown. Note that the boxed ATT in the polyhedrin promoter represents the original start-ATG of the polyhedrin gene (mutated to ATT; see ref.
(1)), which is not used, since the target gene will bring its own ATG start codon. 2) Sequences of the vectors pIDC LIC and pFL LIC used in panel (A), after a sacB expression cassette has been introduced into the BssHII site as a negative selection marker to prepare for LIC. 3) pIDC and pFL vectors carrying a gene and accompanying sequences (orange) introduced by LIC after treating the vectors in 2 with BssHII (removes sacB cassette). For details on LIC see "Materials and Methods" in the main text. The gene starting with the start-ATG (underlined) and ending with a stop codon (T A/G A/G), in some constructs followed by additional nucleotides, as was present on the pcDNA3.1+ vectors, is preceded by a Kozak sequence (ACC, italic) and the sequence "TT". Whereas the first "T" is important for generation of a defined overhang during the T4 polymerase treatment (part of the LIC reaction), the second "T" had been introduced to avoid a placement of the gene inframe to the mutated polyhedrin start-ATG (boxed ATT in 1) and following two ATT's (see ref. (2)). For some constructs additional sequences ("(N) x ") after the stop codon have been carried over for reasons of primer design. This is followed by an "A" that fulfills the same function in the LIC reaction as the first "T".
Additional note: In order to subsequently introduce the β-subunit into "pIDC α LIC" the vector has to be opened by BssHII. As α i1 contains one recognition sequence for this enzyme, the site in α i1 has been removed by silent point mutation in codon no. 31 (numbering includes start ATG) GCG to GCT.
Fig. S2:
Control experiments for the co-immunoprecipitation of Gαβγ heterotrimers. (A) Anti-HA ("HA") or control ("C") beads were incubated either with solubilized G protein (α i1 β 1 HAγ 1 ), with buffer or a solubilizate of mock-infected cells. Proteins bound to the beads were visualized by silver gel. Only in the case of the G protein are three bands visible, which correspond to the α-, β-and γ-subunits. An additional band below the β-subunit (at 34 kDa) can be seen in all lanes. The heavy ("HC") and light ("LC") chain of the antibodies used for the pulldown are also visible. (B) α i1 or α sL were expressed together with HA-γ 2 , but without a β-subunit. As a reference, the full heterotrimeric G protein α i1 β 1 HA-γ 7 was expressed. Those three combinations were solubilized and subjected to a co-immunoprecipitation by anti-HA beads. The western blots detecting the α-and γ-subunit show that both subunits were expressed ("load"), but only in the case of the full G protein the α-subunit is coimmunoprecipitated ("bound"), whereas the γ-subunit is present in all cases, due to its HAtag. It should be noted that the light shadow visible above the expected α sL band in the "bound" lane is due to a crossreactivity of the secondary antibody with the antibody used for the immunoprecipitation. This becomes visible, because the exposure time for the α sLsubunit was higher than for the α i1 -subunit. The supernatant of the beads after incubation with the anti-HA beads is also shown ("sup."). (C) Comparison of the amount of α-, β-and γsubunits before ("load") and after ("sup.") incubation with anti-HA beads. Equal amounts were loaded and analyzed by western blot. No decrease in signal strength after incubation with beads is visible, indicating a saturation of the beads.
Fig. S3
: eYFP fluorescence measured in the cleared supernatants of solubilized G protein expressing cells, which were used for incubation with the antibody-coated beads (coimmunoprecipitation). Since eYFP is co-expressed with the heterotrimeric G-protein complex (see ˮMaterial and Methodsˮ), it can aid as an indicator for general protein expression level of each virus. Interestingly, eYFP fluorescence is generally lowest for G-protein combinations containing γ 12 (and to some extend also γ 3 ). This is an indication that expression of this γsubunit(s) pose a burden for the expression machinery of the cell. This finding may explain why expression levels of G-protein α-and β-subunits, co-expressed especially with γ 12 , are low in Fig. 1 C and D. The generation of new viruses or the use of more virus for expression did not resolve the found differences of expression levels shown in Fig. 1 C and D. The eYFP fluorescence signals were normalized by setting the highest signal to 1 for each group of 12, consisting of defined α-and β-subunit and variable γ-subunit (γ 1-5,7-13 ); i.e., normalization took place within bars of the same color of each chart.
Fig. S4: Results of co-immunoprecipitation experiments. (A) and (B) GTPγS titration experiments. (A)
Anti-HA (α-HA) beads were incubated first with (+) or without (-) G protein (α i1 β 1 HA-γ 1 ). In a second incubation the beads (theoretical concentration of G protein is around 50 nM) were incubated with solubilized GPCR (NTR1 or TM86V L167R) in the presence (+) or absence (-) of agonist (20 µM neurotensin) and the indicated amount of GTPγS (0-750 µM). The protein bound to the beads after washing is visualized by western blot. As an internal loading control the heavy chain of the antibody used for the pull down is shown. The effects of the agonist and GTPγS on the binding of GPCR to the G protein are visualized in (B) by the signal ratio of the GPCR band and the heavy chain of the antibody. Titration of GTPγS reveals that already at 100 nM GTPγS a significant amount of GPCR has been dissociated from the G protein. However, for both GPCRs analyzed the effect was reaching a plateau between 1 and 50 µM GTPγS. We decided to use the rather high GTPγS concentration of 750 µM to secure maximal dissociation in the following experiments. GPCR/G-protein complexes on beads (in a similar concentration range) have been disassembled by the use of a comparable high (100 µM) GTPγS concentration in ref. (3) . (C) Co-immunoprecipitation of G protein (α i1 β 2 HA-γ 1 ) and NTR1 wild-type or TM86V L167R. After incubation of the solubilized G protein with anti-HA beads, the beads were incubated with solubilized GPCR. The presence of GPCR/G protein bound to the beads as a function of the presence of G protein, agonist (20 µM neurotensin) and GTPγS (750 µM) is shown by western blot ("bound"). The blot shows the same behavior of α i1 β 2 HA-γ 1 regarding GPCR interaction as is seen for α i1 β 1 HA-γ 1 , indicating a functional coupling of this newly reported Gprotein combination, which was previously assumed to be non-existent.
Fig. S5: Interaction interfaces and multiple sequence alignments of β-and γ-subunits. (A)
Interaction interface of the bovine β 1 γ 1 (PDB ID: 1TBG) and bovine β 1 γ 2 (1GP2) dimer. Amino acids (one letter code and position number) involved in interaction between β-and γ-subunits are given for each subunit. For a better comparison between γ 1 and γ 2 the corresponding positions of γ 1 are indicated below the amino acids of γ 2 . Amino acids colored in red indicate a full conservation throughout all β-or γ-subunits, orange indicates a full conservation throughout β 1 -β 4 , i.e. excluding β 5, and black indicates more variable positions. Interactions between amino acids of β-and γ-subunits are indicated by solid lines for hydrophobic interactions and dashed lines for hydrogen bonds. Green lines indicate that the interaction between the two positions in β and γ is found in both structures (β 1 γ 1 and β 1 γ 2 ), whereas yellow or blue lines indicate unique interactions found only in β 1 γ 1 or β 1 γ 2 , respectively.
Inspection of the interaction network reveals that 65-70% of interactions are found in both structures. Interactions were defined by an interatomic distance of less than 4 Å and burying of ≥20% of the total solvent-accessible surface area upon interaction. Hydrogen bonds were inspected by eye. Structures were analyzed by the bioinformatic (web)tools ContPro (4), the EBI PDBe PISA web server (5) and PyMOL (Schrödinger).
(B) 10 position identified in (A) in the interaction interface of β 1 that are not conserved throughout β 1 -β 4 . Positions and their corresponding residue in β 2 -β 4 are given. For residues that contact the γ-subunit solely via the peptide backbone, the relevant atoms are indicated in parentheses. Substitutions of β 1 residues to the corresponding residue in β 2 -β 4 that potentially lead to steric clashes in the inspected structures (PDB IDs: 1TBG (β 1 γ 1 ), 1GOT (α t/i1 β 1 γ 1 ), 1GP2 (α i1 β 1 γ 2 ), 3SN6 (α s β 1 γ 2 /β 2 adrenergic receptor complex) and 3AH8 (α i1/q β 1 γ 2 )) are indicated by a flash. A green flash indicates a clash that is found for structures containing β 1 γ 1 and β 1 γ 2 , a yellow flash indicates clashes found for β 1 γ 1 containing structures and a blue flash indicates clashes found for β 1 γ 2 containing structures. Nevertheless, the clashes for position I37 could not be found in structures 1GOT and 3AH8. Steric clashes were analyzed by PyMOL (Schrödinger).
(C) Multiple sequence alignment of γ-subunits. Shown are all human γ-subunits and the bovine γ 1 . Subunits that are 100% identical between human and bovine sequences are indicated with a bov. superscript. Numbering is according to the γ 1 -subunit. Residues involved in interaction with β are highlighted in yellow or blue for γ 1 and γ 2 , respectively. The last three amino acids (boxed red) are removed upon lipid modification of the preceding Cterminal cysteine and are therefore not present in the mature form of the γ-subunits. The point mutation found between human (L40) and bovine (F40) γ 1 -subunit is boxed black. This point mutation has been described to be responsible for the incompatibility between β 2 and γ 1 (6) .
(D) Multiple sequence alignment of all human β-subunits. Numbering is according to the β 1subunit. Residues involved in interaction with γ are highlighted in green, yellow or blue if their interaction with γ has been found in structures of β 1 γ 1 (1TBG) and β 1 γ 2 (1GP2), only β 1 γ 1 or only β 1 γ 2 , respectively.
(E) Multiple sequence alignment of γ 1 , γ 9 and γ 11 . The last three amino acids (boxed red) are removed upon lipid modification of the preceding C-terminal cysteine and are therefore not present in the mature form of the γ-subunits. All alignments were generated by Clustal O (version 1.2.1) at EMBL-EBI (7, 8) . An asterisk indicates positions which are fully conserved. A colon indicates conservation between residues of strongly similar properties (scoring > 0.5 in the Gonnet PAM 250 matrix). A period indicates conservation between groups of weakly similar properties (scoring ≤ 0.5 in the Gonnet PAM 250 matrix).
